Investigational new drugPeptide
Compound 61474
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061474
Risk Class
MODERATE
Last Audit
Feb 27, 2108
Research Abstract
Peptide candidate engineered for cellular repair initiatives with automated dossier coverage.
Compound 61474 is a peptide asset inside peptide innovation track initiatives, optimized for cellular repair and tissue regeneration.
The dossier currently sits in investigational new drug with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061474 with updates logged 2108-02-27.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cellular repairTissue regeneration
Nomenclature
CX-61474Peptide Program 61474
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061474
- [2] Operations Pulse • Peptide innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61474